LATS2 and pancreatic neoplasm: The current study identified a novel ZIP4-CREB-miR-373 signalling axis that promotes pancreatic cancer growth, through silencing on key tumour suppressor molecules including TP53INP1, LATS2 and CD44 (Fig 8).